Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Endocrinology 2, 247 (1 May 2006) | doi:10.1038/ncpendmet0151
Temozolomide and thalidomide effective in treating metastatic neuroendocrine tumors
Abstract
Kulke MH et al. (2006) Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol 24: 401–406 Although medical treatments for hormone-secreting neuroendocrine tumors can help normalize hormone levels, they rarely reduce tumor size.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
